2013, Number 5
<< Back Next >>
Rev Med Inst Mex Seguro Soc 2013; 51 (5)
Relationship among anthropometric and gluco-metabolic parameters, bone mineral density and endometriosis
Nava-González EJ, de la Garza-Casas YE, Salazar-Montalvo RG, Gallegos- Cabriales EC
Language: Spanish
References: 31
Page: 522-531
PDF size: 402.17 Kb.
ABSTRACT
Background: women with endometriosis may have a
decreased bone mineral density (BMD). Several studies
have shown that accumulation of adipose tissue profoundly
affects BMD. It has also been documented that
excess body fat is associated with risk of developing
endometriosis. The aim was to analyze the relationship
between BMD, fat mass, and the insulin-glucose axis in
women with endometriosis.
Methods: thirty women with the diagnosis of endometriosis
established by surgery were enrolled to participate in
an observational prospective study. Anthropometry was
performed to determine body mass index, and a dual
X-ray densitometry to collect data on body composition
and BMD. Glucose and insulin determinations were performed.
Women were divided in two groups: with normal
weight (
n = 18) or overweight (
n = 12). For the analysis of
the results, we used descriptive statistics and Pearson test.
Results: normal weight/overweight: mean age 32.5/35.2
years; body mass index 21.5/30.2; adiposity index:
27.7 %/36.1 %; fat mass index: 35.4/45.8 %; women with
overweight showed a signifi cant value with
p‹ 0.05.
Conclusions: women with overweight, high values of adiposity
index and fat mass index were related with endometriosis.
The importance could support the hypothesis
about a common pathogenesis among endometriosis,
osteoporosis, diabetes and obesity.
REFERENCES
Stilley JA, Birt JA, Sharpe-Timms KL. Cellular and molecular basis for endometriosis-associated infertility. Cell Tissue Res. 2012;349(3):849-62. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3429772/pdf/441_2011_Article_1309.pdf
Allaire C. Endometriosis and infertility: a review. J Reprod Med. 2006;51(3):164-8.
Matalliotakis IM, Cakmak H, Fragouli YG, Goumenou AG, Mahutte NG, Arici A. Epidemiological characteristics in women with and without endometriosis in the Yale series. Arch Gynecol Obstet. 2008;277(5):389-93.
Vitonis AF, Baer HJ, Hankinson SE, Laufer MR, Missmer SA. A prospective study of body size during childhood and early adulthood and the incidence of endometriosis. Hum Reprod. 2010;25(5):1325-34. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2854045/pdf/deq039.pdf
Baldi A, Campioni M, Signorile PG. Endometriosis: pathogenesis, diagnosis, therapy and association with cancer (review). Oncol Rep 2008;19(4):843-6. Texto libre en http://www.spandidos-publications. com/or/19/4/843
Rosen CJ, Klibanski A. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med. 2009;122(5):409-14. Texto libre en http://www.cof.org.cn/pdf/2009/5/Bone,%20 Fat,%20and%20Body%20Composition%20Evolving% 20Concepts%20in%20the%20Pathogenesis% 20of %20Osteoporosis.PDF
Grey A, Bolland M, Gamble G, Wattie D, Horne A, Davidson J, et al. The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab. 2007;92(4): 1305-10.
Goulding A. Risk factors for fractures in normally active children and adolescents. Med Sport Sci. 2007; 51:102-20.
Milewski L, Barcz E, Dziunycz P, Radomski D, Kaminski P, Roszkowski PI, et al. Association of leptin with infl ammatory cytokines and lymphocyte subpopulations in peritoneal fl uid of patients with endometriosis. J Reprod Immunol. 2008;79(1):111-7.
Styer AK, Sullivan BT, Puder M, Arsenault D, Petrozza JC, Serikawa T, et al. Ablation of leptin signaling disrupts the establishment, development, and maintenance of endometriosis-like lesions in a murine model. Endocrinology. 2008;149(2):506-14. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2219296/
DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia. 2010; 53(7):1270-87. Texto libre en http://www.ncbi.nlm. nih.gov/pmc/articles/PMC2877338/pdf/125_2010_ Article_1684.pdf
Unger RH. Lipid overload and overfl ow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab. 2003;14(9):398-403.
Rajpathak SN, Gunter MJ, Wylie-Rosett J, Ho GY, Kaplan RC, Muzumdar R, et al. The role of insulinlike growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab Res Rev. 2009;25(1):3-12.
Kim H, Park JH, Ku SY, Kim SH, Choi YM, Kim JG. Association between endometriosis and polymorphisms in insulin-like growth factors (IGFs) and IGFI receptor genes in Korean women. Eur J Obstet Gynecol Reprod Biol. 2011;156(1):87-90.
Tudor-Locke C, McColl RS. Factors related to variation in premenopausal bone mineral status: a health promotion approach. Osteoporos Int. 2000;11(1):1-24.
Greco EA, Fornari R, Rossi F, Santiemma V, Prossomariti G, Annoscia C, et al. Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index. Int J Clin Pract. 2010;64(6):817-20.
Goulding A, Taylor RW, Jones IE, McAuley KA, Manning PJ, Williams SM. Overweight and obese children have low bone mass and area for their weight. Int J Obesity Relat Metab Disord. 2000;24(5):627-32.
Comite F, Delman M, Huthchinson-Williams K, DeCherney AH, Jensen P. Reduced bone mass in reproductive-aged women with endometriosis. J Clin Endocrinol Metab. 1989;69(4):837-42.
Divasta AD, Laufer MR, Gordon CM. Bone density in adolescents treated with a GnRH agonist and addback therapy for endometriosis. J Pediatr Adolesc Gynecol. 2007;20(5):293-7. Texto libre en http:// www.ncbi.nlm.nih.gov/pmc/articles/PMC3195423/pdf/ nihms330487.pdf
Hearns-Stokes RM, Santoro NF, Simon JA. Surgically induced endometriosis attenuates accrual of bone mineral density in growing rats. Am J Obstet Gynecol. 2001;184(3):331-5.
Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137-41.
Bergman RN, Stefanovski D, Buchanan TA, Sumner AE, Reynolds JC, Sebring NG, et al. A better index of body adiposity. Obesity 2011;19(5):1083-9. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3275633/pdf/nihms352797.pdf
Secretaría de Salud. Ley General de Salud. Decreto del Diario Ofi cial de la Federación, 1987, mayo 27 .
Szalma S, Koka V, Khasanova T, Perakslis ED. Effective knowledge management in translational medicine. J Transl Med. 2010;19(8):68. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2914663/pdf/1479-5876-8-68.pdf
Takemura Y, Osuga Y, Harada M, Hirata T, Koga K, Yoshino O, et al. Concentration of adiponectin in peritoneal fl uid is decreased in women with endometriosis. Am J Reprod Immunol. 2005;54(4):217-21.
Nagle CM, Bell TA, Purdie DM, Treloar SA, Olsen CM, Grover S, et al. Relative weight at ages 10 and 16 years and risk of endometriosis: a case-control analysis. Hum Reprod. 2009;24(6):1501-6.
Goulding A, Taylor RW, Grant AM, Parnell WR, Wilson NC, Williams SM. Waist-to-height ratios in relation to BMI z-scores in three ethnic groups from a representative sample of New Zealand children aged 5-14 years. Int J Obes. 2010;34(7):1188-90.
Zaidi M, Buettner C, Sun L, Iqbal J. Minireview: The link between fat and bone: does mass beget mass? Endocrinology. 2012;153(5):2070-5. Texto libre en http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3339646/
Agarwal SK. Impact of six months of GnRH agonist therapy for endometriosis. Is there an age-related effect on bone mineral density? J Reprod Med. 2002;47(7):530-4.
Pavone ME, Bulun SE. Aromatase inhibitors for the treatment of endometriosis. Fertil Steril. 2012;98(6): 1370-9.
Buck Louis GM, Hediger ML, Peña JB. Intrauterine exposures and risk of endometriosis. Hum Reprod. 2007;22(12):3232-6.